Gil Melmed

Gil Y. Melmed, MD, MS, is the Clinical Director of the Inflammatory Bowel Disease Program and Associate Director of the Karsh Division of Digestive and Liver Diseases at Cedars-Sinai Medical Center in Los Angeles, California. He earned his medical degree from Albert Einstein College of Medicine in the Bronx, New York, and master of science in clinical research from UCLA School of Medicine, Los Angeles. Dr Melmed completed his gastroenterology fellowship at the University of California, Los Angeles.
He has authored or coauthored more than 250 articles in peer-reviewed journals and several book chapters. Dr Melmed has served as Associate Editor of the American Journal of Gastroenterology, an ad hoc reviewer for several journals, and clinical research editor for Inflammatory Bowel Disease. His research interests include clinical outcomes and quality of care in IBD. He has given invited lectures and presentations nationally and internationally on several clinical topics in inflammatory bowel disease, including quality of care and clinical outcomes. He is a committee member of several professional organizations, including the American College of Gastroenterology and the Crohn’s and Colitis Foundation, where he serves as co-chair of the IBD Quality of Care committee. He has led or participated in the development of quality measures for IBD with the American Gastroenterology Association, the Crohn’s and Colitis Foundation, and the Canadian Crohn’s and Colitis organizations.